Brimonidine topical gel - Galderma
At a glance
- Drug Originator SansRosa Pharmaceutical Development
- Drug Licenced by Maruho
- Drug Class Antiglaucomas; Antihypertensives; Bromobenzenes; Diamines; Eye disorder therapies; Imidazoles; Quinoxalines; Skin disorder therapies; Small molecules
- Mechanism of Action Alpha 2 adrenergic receptor agonists
- USA Patent Applicants GALDERMA LABS LP
- USA Patents 17
- NDAs 1
- International Patents 125
- Patent Applications 1,741
Table of Contents
Disclaimer